Anti-LPGAT1 monoclonal antibody

Pre-made anti-LPGAT1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LPGAT1/LPGAT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1103-Ab-1/ GM-Tg-hg-IP1103-Ab-2Anti-Human LPGAT1 monoclonal antibodyHuman
GM-Tg-rg-IP1103-Ab-1/ GM-Tg-rg-IP1103-Ab-2Anti-Rat LPGAT1 monoclonal antibodyRat
GM-Tg-mg-IP1103-Ab-1/ GM-Tg-mg-IP1103-Ab-2Anti-Mouse LPGAT1 monoclonal antibodyMouse
GM-Tg-cynog-IP1103-Ab-1/ GM-Tg-cynog-IP1103-Ab-2Anti-Cynomolgus/ Rhesus macaque LPGAT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1103-Ab-1/ GM-Tg-felg-IP1103-Ab-2Anti-Feline LPGAT1 monoclonal antibodyFeline
GM-Tg-cang-IP1103-Ab-1/ GM-Tg-cang-IP1103-Ab-2Anti-Canine LPGAT1 monoclonal antibodyCanine
GM-Tg-bovg-IP1103-Ab-1/ GM-Tg-bovg-IP1103-Ab-2Anti-Bovine LPGAT1 monoclonal antibodyBovine
GM-Tg-equg-IP1103-Ab-1/ GM-Tg-equg-IP1103-Ab-2Anti-Equine LPGAT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1103-Ab-1/ GM-Tg-hg-IP1103-Ab-2; GM-Tg-rg-IP1103-Ab-1/ GM-Tg-rg-IP1103-Ab-2;
GM-Tg-mg-IP1103-Ab-1/ GM-Tg-mg-IP1103-Ab-2; GM-Tg-cynog-IP1103-Ab-1/ GM-Tg-cynog-IP1103-Ab-2;
GM-Tg-felg-IP1103-Ab-1/ GM-Tg-felg-IP1103-Ab-2; GM-Tg-cang-IP1103-Ab-1/ GM-Tg-cang-IP1103-Ab-2;
GM-Tg-bovg-IP1103-Ab-1/ GM-Tg-bovg-IP1103-Ab-2; GM-Tg-equg-IP1103-Ab-1/ GM-Tg-equg-IP1103-Ab-2
Products NameAnti-LPGAT1 monoclonal antibody
Formatmab
Target NameLPGAT1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LPGAT1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1103-Ag-1Recombinant multi-species LGAT1/ LPGAT1/ FAM34A protein
    ORF Viral VectorvGMLP0025430 LPGAT1 Lentivirus particle
    ORF Viral VectorpGMLP002543human LPGAT1 Lentivirus plasmid
    ORF Viral VectorpGMLPm001475mouse Lpgat1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001475mouse Lpgat1 Lentivirus particle


    Target information

    Target IDGM-IP1103
    Target NameLPGAT1
    Gene ID9926,226856,679692,711398,609933,101085521,541208,100051072
    Gene Symbol and SynonymsFAM34A,FAM34A1,LPGAT1,LPLAT7,NET8
    Uniprot AccessionQ92604
    Uniprot Entry NameLGAT1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000123684
    Target ClassificationN/A

    The target: LPGAT1, gene name: LPGAT1, also named as FAM34A, FAM34A1, NET8. This gene encodes a member of the lysophospholipid acyltransferase family. The encoded protein catalyzes the reacylation of lysophosphatidylglycerol to phosphatidylglycerol, a membrane phospholipid that is an important precursor for the synthesis of cardiolipin. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.